Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-37.24	49.18	78.35
Graham Fair Price	43.17	4.19	2.92
PEG	-99.61	0.19	48.80
Price/Book	-9.43	1.29	1.42
Price/Cash Flow	25.45	19.14	15.26
Prices/Earnings	-56.91	19.33	44.85
Price/Sales	-32.62	1.56	2.31
Price/FCF	25.45	19.14	15.26
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-4.79	0.08	0.09
Operating Margin	36.08	0.03	0.02
ROA	109.93	< 0.005	< 0.005
ROE	< 0.005	0.02	110.20
ROIC	< 0.005	0.01	95.98
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.04	-0.15	71.64
Dividends QOQ	-0.50	3.40	584.06
EBIT QOQ	-0.44	0.81	83.29
EPS QOQ	< 0.005	1.00	10819.64
FCF QOQ	1.98	-0.29	-85.53
Revenue QOQ	-0.29	0.33	14.24
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	66.12	44.81	-32.23
Days Sales Outstanding (DSO)	113.72	90.20	-20.68
Inventory Turnover	1.36	2.01	47.56
Debt/Capitalization	0.48	0.47	-1.64
Quick Ratio	1.16	1.23	5.80
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	6.92	7.67	10.89
Cash	2.58	2.49	-3.37
Capex	-0.01	0.02	43.78
Free Cash Flow	0.65	0.46	-28.70
Revenue	4.27	5.66	32.75
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.60	1.61	0.59
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	21.43	14.11	-34.16
Naive Interpretation	Member

06 - Financial Health · Weak

Rating